Wendy Verret
- Oncology top 2%
- Hepatology top 0.5%
- Pulmonary and Respiratory Medicine top 5%
- Epidemiology top 5%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Andrew X. ZhuRichard S. FinnAhmed O. KasebPeter R. GalleAnn‐Lii ChengMichel DucreuxMasafumi IkedaPhilippe Merle
- Topics
- Advanced Breast Cancer Therapies (20 papers)Hepatocellular Carcinoma Treatment and Prognosis (20 papers)Colorectal Cancer Treatments and Studies (18 papers)
- Cited by
- HepatologyOncologyCancer Research
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Wendy Verret
58 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 1.5k
- Hepatology 1.4k
- Pulmonary and Respiratory Medicine 711
- Epidemiology 474
- Pathology and Forensic Medicine 444
Countries citing papers authored by Wendy Verret
This map shows the geographic impact of Wendy Verret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Verret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Verret more than expected).
Fields of papers citing papers by Wendy Verret
This network shows the impact of papers produced by Wendy Verret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Verret. The network helps show where Wendy Verret may publish in the future.
Co-authorship network of co-authors of Wendy Verret
This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Verret. A scholar is included among the top collaborators of Wendy Verret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Verret. Wendy Verret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 9 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 18 | |
| 8 | Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancerbreakdown → | 176 |
| 9 | 7 | |
| 10 | Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinomabreakdown → | 342 |
| 11 | 4 | |
| 12 | 4 | |
| 13 | 4 | |
| 14 | 62 | |
| 15 | 3 | |
| 16 | 3 | |
| 17 | 19 | |
| 18 | 9 | |
| 19 | 64 | |
| 20 | 14 |
About Wendy Verret
Wendy Verret is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine, having authored 60 papers that have together received 3.0k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers) and Colorectal Cancer Treatments and Studies (18 papers). The work is most often cited by research in Hepatology (1.4k citations), Oncology (1.5k citations) and Cancer Research (423 citations). Wendy Verret has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Andrew X. Zhu, Richard S. Finn, Ahmed O. Kaseb, Peter R. Galle, Ann‐Lii Cheng, Michel Ducreux, Masafumi Ikeda, Philippe Merle, Masatoshi Kudo and Daneng Li. Their work appears in journals such as The Lancet, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.